Savran Technologies offers non-invasive diagnostics based on capture and analysis of rare cells.
Savran Technologies has raised $425K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
Savran Technologies's investors include Walnut Venture Associates, TBD Angels.
Savran Technologies is headquartered in Cambridge, United States.
Savran Technologies offers non-invasive diagnostics based on capture and analysis of rare cells.
Savran Technologies is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Savran Technologies — Funding & Investors." VCBacked, August 30, 2024, https://www.vcbacked.co/company/savran-technologies. Accessed July 20, 2026.
VCBacked. (2024). Savran Technologies — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/savran-technologies
{{cite web |title=Savran Technologies — Funding & Investors |url=https://www.vcbacked.co/company/savran-technologies |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated